Skip to main content
SpringerLink
Log in

CYP3A7*1C Polymorphism, Serum Dehydroepiandrosterone Sulfate Level, and Bone Mineral Density in Postmenopausal Women

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

The CYP3A7 enzyme metabolizes some steroid hormones, including dehydroepiandrosterone sulfate (DHEAS). The age-related decline of serum DHEAS levels is believed to contribute to osteoporosis. Previously, the CYP3A7*1C polymorphism has been shown to cause a persistent high CYP3A7 enzyme activity, resulting in lower levels of DHEAS in men. We hypothesized that the CYP3A7*1C polymorphism might contribute to bone loss through decreased levels of serum DHEAS in postmenopausal women. Postmenopausal women (n = 319) were divided into two subgroups: 217 with osteoporosis and 102 healthy controls. Genotyping, serum DHEAS measurement, and osteodensitometry of the lumbar spine and femoral neck were carried out in all subjects. Homozygous CYP3A7*1C carriers had significantly lower BMD at the lumbar spine compared to wild types (T score −3.27 ± 1.02 in CYP3A7*1C homozygous mutants vs. −1.35 ± 1.53 in wild types, P = 0.041). This association remained significant after adjustment for menopausal age, serum DHEAS level, alcohol consumption, steroid intake, smoking habits, and previous fractures. No association was found between genotypes and serum DHEAS levels in the total study population or in the subgroups. Serum DHEAS levels correlated positively with bone mineral density at the lumbar spine (r = 0.59, P = 0.042) after correction for age. Our data suggest that the CYP3A7 polymorphism might have an influence on bone mass at the lumbar spine independently of serum DHEAS concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y (1987) P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate. J Biol Chem 262:13534–13537

    PubMed  CAS  Google Scholar 

  2. Gonzalez FJ (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243–288

    PubMed  CAS  Google Scholar 

  3. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423

    PubMed  CAS  Google Scholar 

  4. Brooks BA, McBride OW, Dolphin CT, Farrall M, Scambler PJ, Gonzalez FJ, Idle JR (1988) The gene CYP3 encoding P450pcn1 (nifedipine oxidase) is tightly linked to the gene COL1A2 encoding collagen type 1 alpha on 7q21-q22.1. Am J Hum Genet 43:280–284

    PubMed  CAS  Google Scholar 

  5. Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS (1986) Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci USA 83:5311–5315

    Article  PubMed  CAS  Google Scholar 

  6. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264:10388–10395

    PubMed  CAS  Google Scholar 

  7. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y (1985) Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch Biochem Biophys 241:275–280

    Article  PubMed  CAS  Google Scholar 

  8. Westlind A, Malmebo S, Johansson I, Otter C, Andersson TB, Ingelman-Sundberg M, Oscarson M (2001) Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun 281:1349–1355

    Article  PubMed  CAS  Google Scholar 

  9. Greuet J, Pichard L, Bonfils C, Domergue J, Maurel P (1996) The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem Biophys Res Commun 225:689–694

    Article  PubMed  CAS  Google Scholar 

  10. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383–391

    Article  PubMed  CAS  Google Scholar 

  11. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT (2003) Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144:3382–3398

    Article  PubMed  CAS  Google Scholar 

  12. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y (1987) Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem Pharmacol 36:453–456

    Article  PubMed  CAS  Google Scholar 

  13. Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J, Pols HA, Brinkmann AO, de Jong FH, Lamberts SW (2005) A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 90:5313–5316

    Article  PubMed  CAS  Google Scholar 

  14. Hammer F, Subtil S, Lux P, Maser-Gluth C, Stewart PM, Allolio B, Arlt W (2005) No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 90:3600–3605

    Article  PubMed  CAS  Google Scholar 

  15. Haden ST, Glowacki J, Hurwitz S, Rosen C, LeBoff MS (2000) Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif Tissue Int 66:414–418

    Article  PubMed  CAS  Google Scholar 

  16. Koch I, Weil R, Wolbold R, Brockmoller J, Hustert E, Burk O, Nuessler A, Neuhaus P, Eichelbaum M, Zanger U, Wojnowski L (2002) Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30:1108–1114

    Article  PubMed  CAS  Google Scholar 

  17. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T (2003) Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugatu Zasshi 123:369–375

    Article  CAS  Google Scholar 

  18. Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (2005) Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11:7369–7375

    Article  PubMed  CAS  Google Scholar 

  19. Foldes J, Lakatos P, Zsadanyi J, Horvath C (1997) Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism. Eur J Endocrinol 136:277–281

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by grants NKFP-1A/002/2004, NKFP-1A/007/2004, and ETT 022/2006 from the Ministry of Health, Hungary.

Author information

Authors and Affiliations

  1. 1st Department of Medicine, Semmelweis University Budapest, 1083 Korányi S. u 2/a, Budapest, Hungary

    K. Bácsi, J. P. Kósa, G. Borgulya, B. Balla, Á. Lazáry, Z. Nagy, C. Horváth, G. Speer & P. Lakatos

Authors
  1. K. Bácsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. P. Kósa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Borgulya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Balla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Á. Lazáry
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Z. Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Horváth
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Speer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Lakatos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Speer.

Additional information

G. Speer, P. Lakatos contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bácsi, K., Kósa, J.P., Borgulya, G. et al. CYP3A7*1C Polymorphism, Serum Dehydroepiandrosterone Sulfate Level, and Bone Mineral Density in Postmenopausal Women. Calcif Tissue Int 80, 154–159 (2007). https://doi.org/10.1007/s00223-006-0227-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-006-0227-8

Keywords

Search

Navigation